Luc Chouinard

Montreal, QC H3A0C3, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Optimal Sensor Placement for Enhanced Efficiency in Structural Health Monitoring of Medium-Rise Buildings.

Optimal Sensor Placement for Enhanced Efficiency in Structural Health Monitoring of Medium-Rise Buildings.

Journal: Sensors (Basel, Switzerland)

Published: July 24, 2024

Detecting Multiple Damages in UHPFRC Beams through Modal Curvature Analysis.

Detecting Multiple Damages in UHPFRC Beams through Modal Curvature Analysis.

Journal: Sensors (Basel, Switzerland)

Published: December 13, 2023

Inhibition of both sclerostin and DKK1 results in novel skull findings in the rat and non-human primate that is not observed with inhibition of sclerostin alone.

Inhibition of both sclerostin and DKK1 results in novel skull findings in the rat and non-human primate that is not observed with inhibition of sclerostin alone.

Journal: Bone

Published: October 27, 2023

Robust Synchronization of Ambient Vibration Time Histories Based on Phase Angle Compensations and Kernel Density Function.

Robust Synchronization of Ambient Vibration Time Histories Based on Phase Angle Compensations and Kernel Density Function.

Journal: Sensors (Basel, Switzerland)

Published: September 21, 2022

Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs.

Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs.

Journal: Veterinary journal (London, England : 1997)

Published: March 29, 2021

Studies on articular and general toxicity of orally administered ozenoxacin in juvenile rats and dogs.

Studies on articular and general toxicity of orally administered ozenoxacin in juvenile rats and dogs.

Journal: Future microbiology

Published: May 11, 2018

A review of the antibacterial activity of ozenoxacin.

A review of the antibacterial activity of ozenoxacin.

Journal: Future microbiology

Published: May 11, 2018

One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats.

One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats.

Journal: Bone

Published: July 27, 2016

One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.

One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: July 13, 2016

Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study.

Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study.

Journal: Regulatory toxicology and pharmacology : RTP

Published: June 28, 2016

Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.

Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.

Journal: Bone

Published: December 20, 2013

Lasting alterations of the sodium current by short-term hyperlipidemia as a mechanism for initiation of cardiac remodeling.

Lasting alterations of the sodium current by short-term hyperlipidemia as a mechanism for initiation of cardiac remodeling.

Journal: American journal of physiology. Heart and circulatory physiology

Published: November 19, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026